tag site-burden 
Rethinking Clinical Trials
MARCH 1, 2023
To reduce the burden on sites, the study has simplified data reporting by reducing time points data, reducing the number of forms that need to be submitted, and reducing the number of data elements within a form.
Rethinking Clinical Trials
MAY 19, 2023
The data visualization started with a basic list of information needed, including systolic and diastolic data; clinic and home data; raw data numbers, effect of medications on blood pressure; goal ranges; out of range values; customizable goal ranges; patient burden of entry; data variability relative to control, and contextual life event data.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
OCTOBER 12, 2022
We [Philips Pharma Solutions, formerly BioTel Research] have successfully ran multi-site DCE-MRI trials,” said Edward Ashton, PhD, VP, Oncology Imaging, Philips Pharma Solutions. For ASL MR perfusion, water molecules in arterial blood from a feeder artery are magnetically tagged and tracked until they reach the region of interest.
XTalks
NOVEMBER 24, 2022
UniQure will manufacture Hemgenix at its Lexington, Massachusetts site. He said the approval “represents important progress in the development of innovative therapies for those experiencing a high burden of disease associated with this form of hemophilia.”. As part of the deal, uniQure can also receive up to $1.5
pharmaphorum
OCTOBER 4, 2022
The trio are charged with helping to enrol patients across more than 100 clinical sites in the US, with the purpose of engaging and educating study volunteers on the process, collecting the patient information accurately and securely, and enrolling patients onto the project itself.
XTalks
DECEMBER 21, 2022
The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. The pandemic necessitated a shift to off-site, remote and virtual clinical trial options. million for a single infusion.
Pharmaceutical Technology
NOVEMBER 30, 2022
High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% had severe obesity.
Expert insights. Personalized for you.
130 
Let's personalize your content